Pajenda, S.; Kapps, S.; Reiter, T.; Freire, R.; Smits, V.A.J.; Wagner, L.; Gerges, D.; Winnicki, W.; Sunder-Plassmann, G.; Schmidt, A.
Antibody Response against the SARS-CoV-2 Nucleocapsid Protein and Its Subdomains—Identification of Pre-Immunization Status by Human Coronaviruses with Multipanel Nucleocapsid Fragment Immunoblotting. COVID 2021, 1, 105-114.
https://doi.org/10.3390/covid1010009
AMA Style
Pajenda S, Kapps S, Reiter T, Freire R, Smits VAJ, Wagner L, Gerges D, Winnicki W, Sunder-Plassmann G, Schmidt A.
Antibody Response against the SARS-CoV-2 Nucleocapsid Protein and Its Subdomains—Identification of Pre-Immunization Status by Human Coronaviruses with Multipanel Nucleocapsid Fragment Immunoblotting. COVID. 2021; 1(1):105-114.
https://doi.org/10.3390/covid1010009
Chicago/Turabian Style
Pajenda, Sahra, Sebastian Kapps, Thomas Reiter, Raimundo Freire, Veronique A. J. Smits, Ludwig Wagner, Daniela Gerges, Wolfgang Winnicki, Gere Sunder-Plassmann, and Alice Schmidt.
2021. "Antibody Response against the SARS-CoV-2 Nucleocapsid Protein and Its Subdomains—Identification of Pre-Immunization Status by Human Coronaviruses with Multipanel Nucleocapsid Fragment Immunoblotting" COVID 1, no. 1: 105-114.
https://doi.org/10.3390/covid1010009
APA Style
Pajenda, S., Kapps, S., Reiter, T., Freire, R., Smits, V. A. J., Wagner, L., Gerges, D., Winnicki, W., Sunder-Plassmann, G., & Schmidt, A.
(2021). Antibody Response against the SARS-CoV-2 Nucleocapsid Protein and Its Subdomains—Identification of Pre-Immunization Status by Human Coronaviruses with Multipanel Nucleocapsid Fragment Immunoblotting. COVID, 1(1), 105-114.
https://doi.org/10.3390/covid1010009
